Table 2.
v.n. | 1 day of life | 10 days of life | 14 days of life | 30 days of life | 45 days of life | 60 days of life | 88 days of life | 110 days of life | |
---|---|---|---|---|---|---|---|---|---|
17-OH-P ng/ml | 0.6–3.3 | 1.9 | |||||||
DHEA-solf. μg/ml | 0.2–6.9 | 0.2 | |||||||
Delta 4 andros. ng/ml | 0.3–3.1 | 0.3 | |||||||
AVM (mg/24 h) | 1–11 | 0.4 | |||||||
AOV (mg/g creat.) | 0.5–35 | 17.1 | |||||||
Noradrenaline ug/24 h | 6 | ||||||||
ACTH pg/ml | 4.7–49 | 107.8 | 149.6 | 46.4 | 57.3 | 24.8 | 46.8 | ||
Cortisol μ/dl | 6.7–22.6 | 6.8 | 5.3 | 6.6 | 3.7 | 10.4 | 6.7 | 9.1 | |
Aldosterone/renin ratio | < 5.2 | 0.8 | |||||||
Blood culture | N | ||||||||
Urine culture | N |
17-OH-P 17-hydroxyprogesterone, DHEA-solf. Dehydroepiandrosterone sulphate, Delta 4 andros. Delta 4 Androstenedione, AVM Vanillylmandelic acid, AOV Homovanillic acid, ACTH Adrenocorticotropic hormone